IMI's PRO-active project has developed patient-centred tools and approaches to help people with chronic obstructive respiratory disease (COPD) get more personalised treatments - a means to boost their activity levels, health and well-being.
Improvements in life expectancy are slowing down across Europe. An OECD-commissioned report attempts to unpick the reasons and calls for countries to step-up research and monitoring of mortality
European Court of Auditors says it will investigate whether EU attempts to tackle antibiotic resistance provide value for money, on same day that health and food agencies say the problem is getting worse
Novel therapies being developed by IMI-funded researchers could help to prevent and cure rheumatoid arthritis by tackling the autoimmune disease in the very early stages, before debilitating symptoms appear.
New open access tools for drug development, obesity, and the environmental impacts of medicines are the focus of a new Innovative Medicines Initiative Call for proposals.
Commission R&D funding for neglected diseases rose by 50 per cent in 2017. The UK and US remain the biggest funders - and UK spending increased by 89 per cent, says Australian charity
A leading geneticist recounts the story of one rogue scientist, and the damage he caused. ‘He should be stopped from doing anything like this again,’ says Robin Lovell-Badge
Receive the Funding Newswire [full access requires a subscription] each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.